Advantages and Disadvantages of Current Lentiviral Vector Platforms

Time: 2:00 pm
day: Track A - Day 2 PM


  • This talk will focus on current Lentiviral Vector manufacturing platforms for cell and gene therapy applications
  • Elevate bio strategic efforts to develop a GMP-ready, scalable, and robust Lentiviral Vector process based on transient transfection of suspension growing cultures will be presented